Phio Pharmaceuticals Corp.
RNA INTERFERENCE IN OCULAR INDICATIONS
Last updated:
Abstract:
The present invention relates to ocular administration of sd-rxRNA and rxRNAori molecules.
Status:
Application
Type:
Utility
Filling date:
12 May 2020
Issue date:
4 Mar 2021